OptumRx WatchList Includes Rare Disease Drugs, Potential Price Disruptors

 
• By Cathy Kelly

Pharmacy benefit manager’s new pipeline report offers insight into upcoming drugs of concern to payers.

Value-Cost
OptumRx Previews Coverage Climate For Five Upcoming Drugs

More from Business

More from Scrip